Skip to main content
Top
Published in: International Journal of Colorectal Disease 9/2020

01-09-2020 | Wound Infection | Review

Simultaneous versus staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases: a meta-analysis of outcomes and clinical characteristics

Authors: Shahin Hajibandeh, Shahab Hajibandeh, Abida Sultana, Gabriella Ferris, Josiah Mwendwa, Ali Yasen Y. Mohamedahmed, Shafquat Zaman, Rajeev Peravali

Published in: International Journal of Colorectal Disease | Issue 9/2020

Login to get access

Abstract

Objectives

To evaluate the comparative outcomes and clinical characteristics of simultaneous and staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases.

Methods

We conducted a systematic search of electronic information sources, and bibliographic reference lists. Perioperative morbidity and mortality, anastomotic leak, wound infection, bile leak, bleeding, intra-abdominal abscess, sub-phrenic abscess, reoperation, recurrence, 5-year overall survival, procedure time, and length of hospital stay were the evaluated outcome parameters. Combined overall effect sizes were calculated using random-effects model.

Results

We identified 41 comparative studies reporting a total of 12,081 patients who underwent simultaneous (n = 5013) or staged (n = 7068) resections for colorectal cancer with synchronous hepatic metastases. There were significantly lower use of neoadjuvant chemotherapy (p = 0.003), higher right-sided colonic resections (p < 0.00001), and minor hepatic resections (p < 0.00001) in the simultaneous group. The simultaneous resection was associated with significantly lower rate of bleeding (OR 0.60, p = 0.03) and shorter length of hospital stay (MD − 5.40, p < 0.00001) compared to the staged resection. However, no significant difference was found in perioperative morbidity (OR1.04, p = 0.63), mortality (RD 0.00, p = 0.19), anastomotic leak (RD 0.01, p = 0.33), bile leak (OR 0.83, p = 0.50), wound infection (OR 1.17, p = 0.19), intra-abdominal abscess (RD 0.01, p = 0.26), sub-phrenic abscess (OR 1.26, p = 0.48), reoperation (OR 1.32, p = 0.18), recurrence (OR 1.33, p = 0.10), 5-year overall survival (OR 0.88, p = 0.19), or procedure time (MD − 23.64, p = 041) between two groups.

Conclusions

Despite demonstrating nearly comparable outcomes, the best available evidence (level 2) regarding simultaneous and staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases is associated with major selection bias. It is time to conduct high-quality randomised studies with respect to burden and laterality of disease. We recommend the staged approach for complex cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference McMillan DC, McArdle CS (2007) Epidemiology of colorectal liver metastases. Surg Oncol 16:3–5CrossRef McMillan DC, McArdle CS (2007) Epidemiology of colorectal liver metastases. Surg Oncol 16:3–5CrossRef
2.
go back to reference Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef
3.
go back to reference Lochan R, White SA, Manas DM (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16:33–45CrossRef Lochan R, White SA, Manas DM (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16:33–45CrossRef
4.
go back to reference Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–1280CrossRef Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–1280CrossRef
5.
go back to reference Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318 discussion 18–21CrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318 discussion 18–21CrossRef
6.
go back to reference Serrano PE, Gu CS, Husien M, Jalink D, Ritter A, Martel G et al (2019) Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. J Surg Oncol Serrano PE, Gu CS, Husien M, Jalink D, Ritter A, Martel G et al (2019) Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. J Surg Oncol
7.
go back to reference Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C (1987) Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205:256–263CrossRef Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C (1987) Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205:256–263CrossRef
8.
go back to reference Martin RC 2nd, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208:842–850CrossRef Martin RC 2nd, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208:842–850CrossRef
11.
go back to reference Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRef Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRef
15.
go back to reference Jaeck D, Bachellier P, Weber JC et al (1999) Stratégie chirurgicale dans le traitement des métastases hépatiques synchrones des cancers colorectaux. Analyse d’une série de 59 malades opérés [Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients]. Chirurgie. 124(3):258–263. https://doi.org/10.1016/s0001-4001(99)80091-9 CrossRefPubMed Jaeck D, Bachellier P, Weber JC et al (1999) Stratégie chirurgicale dans le traitement des métastases hépatiques synchrones des cancers colorectaux. Analyse d’une série de 59 malades opérés [Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients]. Chirurgie. 124(3):258–263. https://​doi.​org/​10.​1016/​s0001-4001(99)80091-9 CrossRefPubMed
29.
go back to reference Slupski M, Wlodarczyk Z, Jasinski M, Masztalerz M, Tujakowski J (2009) Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg 52(6):E241–E244PubMedPubMedCentral Slupski M, Wlodarczyk Z, Jasinski M, Masztalerz M, Tujakowski J (2009) Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg 52(6):E241–E244PubMedPubMedCentral
31.
go back to reference Moug SJ, Smith D, Leen E, Roxburgh C, Horgan PE (2010) Evidence for a synchronous operative approach in the treatment of colorectal cancer with hepatic metastases: a case matched study. Eur J Surg Oncol 36:365–370CrossRef Moug SJ, Smith D, Leen E, Roxburgh C, Horgan PE (2010) Evidence for a synchronous operative approach in the treatment of colorectal cancer with hepatic metastases: a case matched study. Eur J Surg Oncol 36:365–370CrossRef
32.
go back to reference Kaibori M, Iwamoto S, Ishizaki M, Matsui K, Saito T, Yoshioka K et al (2010) Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sci 55:3262–3270CrossRef Kaibori M, Iwamoto S, Ishizaki M, Matsui K, Saito T, Yoshioka K et al (2010) Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sci 55:3262–3270CrossRef
33.
go back to reference Luo Y, Wang L, Chen C, Chen D, Huang M, Huang Y et al (2010) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Gastrointest Surg 14:1974–1980CrossRef Luo Y, Wang L, Chen C, Chen D, Huang M, Huang Y et al (2010) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases. J Gastrointest Surg 14:1974–1980CrossRef
34.
go back to reference de Haas RJ, Adam R, Wicherts DA, Azoulay D, Bismuth H, Vibert E et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous liver metastases. Br J Surg 97:1279–1289CrossRef de Haas RJ, Adam R, Wicherts DA, Azoulay D, Bismuth H, Vibert E et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous liver metastases. Br J Surg 97:1279–1289CrossRef
35.
go back to reference Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ et al (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210:934–941CrossRef Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ et al (2010) Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210:934–941CrossRef
36.
go back to reference Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S et al (2012) Optimizing clinical and economic outcomes for surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215:262–270CrossRef Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S et al (2012) Optimizing clinical and economic outcomes for surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215:262–270CrossRef
37.
go back to reference Sc M, Pulitano C, Marques H, Lamelas J, Wolfgang CL, de Saussure W et al (2013) Surgical management of patients with synchronous colorectal liver metastases: a multicenter international analysis. J Am Coll Surg 216:707–718CrossRef Sc M, Pulitano C, Marques H, Lamelas J, Wolfgang CL, de Saussure W et al (2013) Surgical management of patients with synchronous colorectal liver metastases: a multicenter international analysis. J Am Coll Surg 216:707–718CrossRef
38.
go back to reference Bigourdan JM, Faber B, Rayar M, Chirpaz E, Boucher E, Boudjema K (2014) Disease-Free survival after simultaneous or delayed resection of synchronous colorectal liver metastasis and primary cancer. Hepatogastroenterology 61(132):1074–1081PubMed Bigourdan JM, Faber B, Rayar M, Chirpaz E, Boucher E, Boudjema K (2014) Disease-Free survival after simultaneous or delayed resection of synchronous colorectal liver metastasis and primary cancer. Hepatogastroenterology 61(132):1074–1081PubMed
39.
go back to reference Patrono D, Paraluppi G, Perino M, Palisi M, Migliaretti G, Berchialla P et al (2014) Posthepatectomy liver failure after simultaneous versus staged resection for colorectal cancer and synchronous hepatic metastases. G Chir 35:86–93PubMedPubMedCentral Patrono D, Paraluppi G, Perino M, Palisi M, Migliaretti G, Berchialla P et al (2014) Posthepatectomy liver failure after simultaneous versus staged resection for colorectal cancer and synchronous hepatic metastases. G Chir 35:86–93PubMedPubMedCentral
40.
go back to reference She WH, Chan ACY, Poon RTP, Cheung TT, Chok KSH, Chan SC et al (2015) Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg 85:829–833CrossRef She WH, Chan ACY, Poon RTP, Cheung TT, Chok KSH, Chan SC et al (2015) Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg 85:829–833CrossRef
42.
go back to reference Silberhumer GR, Paty PB, Denton B, Guillen J, Genen M, Araujo RLC et al (2016) Long-term outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery 160:67–73CrossRef Silberhumer GR, Paty PB, Denton B, Guillen J, Genen M, Araujo RLC et al (2016) Long-term outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery 160:67–73CrossRef
43.
go back to reference Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Onze S, Isogai M (2016) Simultaneous resection for colorectal cancer and synchronous liver metastases. Surg Today 46:176–182CrossRef Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Onze S, Isogai M (2016) Simultaneous resection for colorectal cancer and synchronous liver metastases. Surg Today 46:176–182CrossRef
48.
go back to reference Inoue Y, Imai Y, Osumi W et al (2017) What is the optimal timing for liver surgery of resectable synchronous liver metastases from colorectal cancer? Am Surg 83(1):45–53PubMed Inoue Y, Imai Y, Osumi W et al (2017) What is the optimal timing for liver surgery of resectable synchronous liver metastases from colorectal cancer? Am Surg 83(1):45–53PubMed
49.
go back to reference Yokomizo H, Okayama S, Yamada Y et al (2018) Treatment outcomes of curative resection for colorectal cancer with synchronous liver metastasis. Gan To Kagaku Ryoho 45(13):2249–2251PubMed Yokomizo H, Okayama S, Yamada Y et al (2018) Treatment outcomes of curative resection for colorectal cancer with synchronous liver metastasis. Gan To Kagaku Ryoho 45(13):2249–2251PubMed
51.
go back to reference Le Souder EB, Azin A, Hirpara DH, Walker R, Cleary S, Quereshy F (2018) Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model. J Surg Oncol 117(7):1376–1385CrossRef Le Souder EB, Azin A, Hirpara DH, Walker R, Cleary S, Quereshy F (2018) Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model. J Surg Oncol 117(7):1376–1385CrossRef
52.
53.
go back to reference Kye BH, Lee SH, Jeong WK et al (2019) Which strategy is better for resectable synchronous liver metastasis from colorectal cancer, simultaneous surgery, or staged surgery? Multicenter retrospective analysis. Ann Surg Treat Res 97(4):184–193CrossRef Kye BH, Lee SH, Jeong WK et al (2019) Which strategy is better for resectable synchronous liver metastasis from colorectal cancer, simultaneous surgery, or staged surgery? Multicenter retrospective analysis. Ann Surg Treat Res 97(4):184–193CrossRef
59.
go back to reference Hozo S, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRef Hozo S, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13CrossRef
Metadata
Title
Simultaneous versus staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases: a meta-analysis of outcomes and clinical characteristics
Authors
Shahin Hajibandeh
Shahab Hajibandeh
Abida Sultana
Gabriella Ferris
Josiah Mwendwa
Ali Yasen Y. Mohamedahmed
Shafquat Zaman
Rajeev Peravali
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 9/2020
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-020-03694-9

Other articles of this Issue 9/2020

International Journal of Colorectal Disease 9/2020 Go to the issue